Register entry
Vovantis Laboratories Private Limited
- Registered sites
- 1
- Drug products
- 16
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Finished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Vovantis Laboratories Private Limited | VadodaraIndia | Finished drug manufacture | 3008132370 |
Catalogue
Marketed products
16Showing 16 of 16.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Diphenhydramine Hydrochloride | TABLET, EFFERVESCENT | DRUG FOR FURTHER PROCESSING |
| - | Psyllium Husk | POWDER | DRUG FOR FURTHER PROCESSING |
| - | Pyrantel Pamoate | GRANULE | DRUG FOR FURTHER PROCESSING |
| - | Pyrantel Pamoate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Pyrantel Pamoate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Pyrantel Pamoate | GRANULE | DRUG FOR FURTHER PROCESSING |
| - | SENNOSIDES | TABLET | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen | TABLET, EFFERVESCENT | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen | TABLET, EFFERVESCENT | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen | TABLET, EFFERVESCENT | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride | TABLET, EFFERVESCENT | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen, dextromethorphan hydrobromide | GRANULE | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen, dextromethorphan hydrobromide | GRANULE | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen, dextromethorphan hydrobromide | GRANULE | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen, dextromethorphan hydrobromide, chlorpheniramine maleate | GRANULE | DRUG FOR FURTHER PROCESSING |
| - | acetaminophen, dextromethorphan hydrobromide, chlorpheniramine maleate | GRANULE | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.